Enhancing Lives with Transformative Therapies

Xenetic Biosciences is a biopharmaceutical company focused on the acquisition, research and development of novel oncology therapeutics, including next-generation cellular immunotherapies for difficult to treat cancers, including B-cell Lymphomas, as well as improved biologic drugs.

More About Us

Combating Disease Through Innovative Therapies

Product Pipeline

Expanding the Potential of CAR T Cell Therapy

Our XCART platform is a novel CAR T technology engineered to target patient- and tumor-specific neoantigens.

XCART Platform

Transformative Technologies

Our proprietary and patented technologies are being utilized to create life-changing therapies.

Our Novel Technologies

Stock InformationView Detailed Stock Information

Nasdaq: XBIO Xenetic Biosciences, Inc.
Price
Change
Volume
Day Range
52 Week Range
Investors Presentation

Get Email Alerts

Stay informed about our latest news and updates

Sign up Today